Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.37 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17523190 | 0.91 | LMNA (0.39) | LMNAKDM4EMEN1MAPTRAB9A | |
| SCHEMBL20249889 | 0.89 | PDK2 (0.43) | PDK2AKR1A1AKR1B1LMNAKCNN4 | |
| SCHEMBL24470247 | 0.87 | MEN1 (0.42) | PDK2LMNAKDM4EMEN1MAPT | |
| SCHEMBL9927247 | 0.87 | MEN1 (0.42) | PDK2LMNAKDM4EMEN1MAPT | |
| SCHEMBL20249881 | 0.86 | PDK2 (0.35) | PDK2AKR1A1AKR1B1LMNAKCNN4 | |
| SCHEMBL20249886 | 0.86 | PDK2 (0.37) | PDK2LMNAKCNN4KCNA5TOP1 | |
| SCHEMBL20249876 | 0.84 | PDK2 (0.38) | PDK2AKR1A1AKR1B1LMNAKCNN4 | |
| SCHEMBL10299019 | 0.83 | LMNA (0.42) | LMNAKDM4EMEN1MAPTRAB9A | |
| SCHEMBL21123246 | 0.82 | LMNA (0.33) | LMNAKDM4EMEN1MAPTRAB9A | |
| SCHEMBL11991040 | 0.81 | PDK2 (0.42) | PDK2LMNATOP1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180166639-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-06-14 | — | — | US | disclosed |
| US-20180166639-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180166639-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | RCC1, CCNA1, CTCF | PDK2 2677/4885AKR1A1 2256/4885AKR1B1 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.